Abstract
Neuropathic pain triggers a cascade of events in the sensory neurons. It is the main complication of diabetes after cardiovascular disease. Nitric oxide (NO) produced from nitric oxide synthases (NOS) is an important signaling molecule which is crucial for many physiological processes such as synaptic plasticity, neuronal survival, vasodilation, vascular homeostasis, immune regulation. Overproduction of NO due to changes in NOS isoforms level involves pathological processes such as neurotoxicity, septic shock and neuropathic pain. All three isoforms of NOS as well as their end product, NO have modulatory effect on neuropathic pain. Overactivation of the N-Methyl-d-Aspartate receptor and peroxynitrite formation results in high levels of neuronal NOS (nNOS) and endothelial NOS (eNOS) which suggest that nNOS and eNOS are critical for pain hypersensitivity. Inducible NOS induced in glia by inflammation due to activation of Tumor Necrosis Factor α, Calcitonin Gene Regulating Peptide, Mitogen Activated Protein Kinases, Extracellular signal Regulated Kinase, c-Jun N-terminal kinases can induce neuronal death. This review focuses on different nitric oxide synthases and their role in pathophysiology of neuropathic pain considering NOS as an important therapeutic target.
Similar content being viewed by others
References
Alvarez S, Moldovan M, Krarup C (2008) Acute energy restriction triggers Wallerian degeneration in mouse. Exp Neurol 212:166–178
Antosova M et al (2012) Nitric oxide—important messenger in human body. Open J Mol Integr Physiol 2(3):9. Art No. 21845
Baron R (2000) Neuropathic pain. The long path from mechanisms to mechanism-based treatment. Anaesthesist 49(5):373–386
Borsani E, Giovannozzi S, Cocchi MA, Boninsegna R, Rezzani R, Rodella LF (2012) Endothelial nitric oxide synthase in dorsal root ganglia during chronic inflammatory nociception. Cells Tissues Organs 197(2):159–168
Boulton AJ (2007) Diabetic neuropathy: classification, measurement and treatment. Curr Opin Endocrinol Diabetes Obes 14:141–145
Brown GC (2010) Nitric oxide and neuronal death. Nitric Oxide 23:153–165
Burnstock G (2006) Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther 110:433–454
Calabrese V, Mancuso C, Calvani C et al (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 10:766–775
Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP (2000) Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184:409–420
Cellek S (2004) Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complications. Curr Pharm Des 10:3683–3695
Cho HS, Shin YS, Lee YH, Cho WH, Ko YK (2009) Relationship between neuronal nitric oxide synthase and NADPH-diaphorase in the dorsal root ganglia during neuropathic pain. Korean J Anesthesiol 57(3):342–349
Chu YC, Guan Y, Skinner J, Raja SN, Johns RA, Tao YX (2005) Effect of genetic knockout or pharmacological inhibition of neuronal nitric oxide synthase on complete Freund’s adjuvant-induced persistent pain. Pain 119:113–123
Cizkova D, Lukacova N, Marsala M, Marsala J (2002) Neuropathic pain is associated with alterations of nitric oxide synthase immunoreactivity and catalytic activity in dorsal root ganglia and spinal dorsal horn. Brain Res Bull 58:161–171
Coleman JW (2001) Nitric oxide in immunity and inflammation. Int Immunopharmacol 1:1397–1406
Day AS, Lue JH, Sun WZ, Shieh JY, Wen CY (2001) A beta-fiber intensity stimulation of chronically constricted median nerve induces c-fos expression in thalamic projection neurons of the cuneate nucleus in rats with behavioral signs of neuropathic pain. Brain Res 895:194–203
de la Puente B, Nadal X, Portillo-Salido E, Sanchez-Arroyos R, Ovalle S, Palacios G et al (2009) Sigma-1 receptors regulate activity-induced spinal sensitisation and neuropathic pain after peripheral nerve injury. Pain 145:294–303
Dogonay S, Evereklioglu C, Turkoz Y, Servinc A, Mehmet N, Savli H (2002) Comparison of serum NO, TNF-α, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16:163–170
Förstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33(7):829–837
Gallo EF, Iadecola C (2011) Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase. J Neurosci 31:6947–6955
Gao X, Kim HK, Chung JM, Chung K (2007) Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain. Pain 131:262–271
Guix FX, Uribesalgo I, Coma M, Muñoz FJ (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76:126–152
Ha HC, Hester LD, Snyder SH (2002) Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA 99:3270–3275
Hamza M, Wang XM, Wu T et al (2010) Nitric oxide is negatively correlated to pain during acute inflammation. Mol Pain 6:55
Hansson P, Backonja M, Bouhassira D (2007) Usefulness and limitations of quantitative sensory testing: clinical and research application in neuropathic pain states. Pain 129:256–259
Hara MR, Snyder SH (2007) Cell signaling and neuronal death. Ann Rev Pharmacol Toxicol 47:117–141
Heltianu C, Guja C, Manea SA (2011) Genetic determinants of microvascular complications in type 1 diabetes. Type 1:3–28
John G (2008) Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27(11):2783–2802
Kakita H, Aoyama M, Nagaya Y, Asai H, Hussein MH, Suzuki M, Kato S, Saitoh S, Asai K (2013) Diclofenac enhances proinflammatory cytokine induced phagocytosis of cultured microglia via nitric oxide production. Toxicol Appl Pharmacol 268:99–105
Keswani SC, Bosch-Marcé M, Reeda N, Fischer A, Semenza GL et al (2011) Nitric oxide prevents axonal degeneration by inducing HIF-1 dependent expression of erythropoietin. Proc Natl Acad Sci USA 108:4986–4990
Kiguchi N, Maeda T, Kobayashi Y, Fukazawa Y, Kishioka S (2010) Macrophage inflammatory protein-1 alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1 beta up-regulation. Pain 149:305–315
Kim HW, Kwon YB, Roh DH, Yoon SY, Han HJ, Kim KW et al (2006) Intrathecal treatment with sigma 1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice. Br J Pharmacol 148:490–498
Kim HW, Roh DH, Yoon SY, Seo HS, Kwon YB, Han HJ et al (2008) Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice. Br J Pharmacol 154:1125–1134
Kiryu-Seo S, Ohno N, Kidd GJ, Komuro H, Trapp BD (2010) Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci 30:6658–6666
Labinskyy N, Hicks S, Grijalva J, Edwards J (2010) The contrary impact of diabetes and exercise on endothelial nitric oxide synthase function. WebmedCentral Physiology 1(12):WMC001376
Levy D, Zochodne DW (2004) NO pain: potential roles of nitric oxide in neuropathic pain. Pain Pract 4:11–18
Levy D, Kubes P, Zochodne DW (2001) Delayed peripheral nerve degeneration, regeneration, and pain in mice lacking inducible nitric oxide synthase. J Neuropathol Exp Neurol 60(5):411–421
Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22–32
Linares D, Taconis M, Mana P, Correcha M, Fordham S, Staykova M et al (2006) Neuronal nitric oxide synthase plays a key role in CNS demyelination. J Neurosci 26:12672–12681
Luo ZD, Cizkova D (2000) The role of nitric oxide in nociception. Current Rev Pain 4(6):459–466
Maurice T, Su TP (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124:195–206
McCarberg BH, Billington R (2006) Consequences of neuropathic pain: quality of life issues and associated costs. Am J Manag Care 12:S263–S268
Miller RJ, Jung H, Bhangoo SK, White FA (2009) Cytokine and chemokine regulation of sensory neuron function. In: Sensory Nerves. Springer, Berlin, Heidelberg, pp 417–449
Moalem G, Tracey DJ (2006) Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 51:240–264
Mukherjee P, Cinelli MA, Kang S, Silverman RB (2014) Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain. Chem Soc Rev. doi:10.1039/C3CS60467E
Narenjkar J, Roghani M, Alambeygi H, Sedaghati F (2011) The effect of the flavonoid quercetin on pain sensation in diabetic rats. Basic Clin Neurosci 2(3):51–57
Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ (2001) Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21:5027–5035
Pannu R, Singh I (2006) Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem Int 49(2):170–182
Pavlov VIA, Obrosova IG (2008) Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia 51(11):2126–2133
Persechini A, Tran QK, Black DJ, Gogol EP (2013) Calmodulin-induced structural changes in endothelial nitric oxide synthase. FEBS Lett 587(3):297–301
Premkumar LS, Pabbidi RM (2013) Diabetic peripheral neuropathy: role of reactive oxygen and nitrogen species. Cell Biochem Biophys 67(2):373–383
Purwata TE (2011) High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy. J Pain Res 4:169
Renganathan M, Cummins TR, Waxman SG (2002) Nitric oxide blocks fast, slow, and persistent Na + channels in C-type DRG neurons by S-nitrosylation. J Neurophysiol 87(2):761–775
Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB, Kim KW et al (2008a) Intrathecal administration of sigma-1 receptor agonists facilitates nociception: involvement of a protein kinase C-dependent pathway. J Neurosci Res 86:3644–3654
Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB, Kim KW et al (2008b) Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain. Anesthesiology 109:879–889
Roh DH, Yoon SY, Seo HS, Kang SY, Moon JY, Song S et al (2010) Sigma-1 receptor-induced increase in murine spinal NR1 phosphorylation is mediated by the PKCalpha and varepsilon, but not the PKCzeta, isoforms. Neurosci Lett 477:95–99
Roh DH, Choi SR, Yoon SY, Kang SY, Moon JY, Kwon SG, Lee JH (2011) Spinal neuronal NOS activation mediates sigma-1 receptor-induced mechanical and thermal hypersensitivity in mice: involvement of PKC-dependent GluN1 phosphorylation. Br J Pharmacol 163(8):1707–1720
Saha RN, Pahan K (2006) Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 8(5–6):929–947
Satoh J, Yagihashi S, Toyota T (2003) The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Exp Diabesity Res 4:65–71
Schmidtko A, Tegeder I, Geisslinger G (2009) No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends Neurosci 32(6):339–346
Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361–1368
Schwiebert EM (2000) Extracellular ATP-mediated propagation of Ca(2+) waves. Focus on mechanical strain-induced Ca(2+) waves are propagated via ATP release and purinergic receptor activation. Am J Physiol Cell Physiol 279:C281–C283
Shaikh AS, Somani RS (2010) Animal models and biomarkers of neuropathy in diabetic rodents. Indian J Pharmacol 42:3
Sharma S, Chopra K, Kulkarni SK (2007) Effect of insulin and its combination with resveratrol or curcumin in attention of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 21:278–283
Sima A, Hideki Kamiya AF (2006) Diabetic neuropathy differs in type 1 and type 2 diabetes. Ann NY Acad Sci 1084(1):235–249
Smith BC, Underbakke ES, Kulp DW, Schief WR, Marletta MA (2013) Nitric oxide synthase domain interfaces regulate electron transfer and calmodulin activation. Proc Natl Acad Sci 110(38):E3577–E3586
Stavniichuk R, Shevalye H, Lupachyk S et al (2014) Peroxynitrite and protein nitrationin the pathogenesis of diabetic peripheral neuropathy. Diabetes Metab Res Rev. doi:10.10002/dmrr.2549
Stuehr DJ, Griffith OW (2006) Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 65:287–346
Tanabe M et al (2009) Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacol 56(3):702–708
Taylor-Clark TE, Ghatta S, Bettner W, Undem BJ (2009) Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1. Mol Pharmacol 75(4):820–829
Thomas MS, Zhang W, Jordan PM, Saragovi HU, Taglialatela G (2005) Signaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cells. J Neuroinflammation 2:19
Toda N, Imamura T, Okamura T (2010) Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus. Pharmacol Ther 127:189–209
Treede RD, Jensen TS, Campbell JN et al (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70:1630–1635
Vallance P, Leiper J (2002) Blocking NO synthesis: how, where and why? Nat Rev Drug Discov 1:939–950
Vareniuk I, Pacher P, Pavlov IA, Drel VR, Obrosova IG (2009) Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency. Int J Mol Med 23(5):571
Vause CV, Durham PL (2009) CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involve mitogen-activated protein kinase pathways. J Neurochem 110:811–821
Viaro F, Nobre F, Evora PRB (2000) Expression of nitric oxide synthases in the pathophysiology of cardiovascular diseases. Arq Bras Cardiol 74(4):380–393
Wang HY, Tsai YJ, Chen SH, Lin CT, Lue JH (2012) Nitric oxide implicates c-Fos expression in the cuneate nucleus following electrical stimulation of the transected median nerve. Neurochem Res 37:84–95
Wang HY, Tsai YJ, Chen SH, Lin CT, Lue JH (2013) Lysophosphatidylcholine causes neuropathic pain via the increase of neuronal nitric oxide synthase in the dorsal root ganglion and cuneate nucleus. Pharmacol Biochem Behav 106:47–56
Yang HC, Auh QS, Lee J, Ro JY (2012) Masseter inflammation differentially regulates three nitric oxide synthases in the rat trigeminal subnucleus caudalis. Arch Oral Biol 57:1141–1146
Zhang N, Inan S, Cowan A, Sun R, Wang JM, Rogers TJ, Caterina M, Oppenheim JJ (2005) A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc Natl Acad Sci USA 102:4536–4541
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahlawat, A., Rana, A., Goyal, N. et al. Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain. Inflammopharmacol 22, 269–278 (2014). https://doi.org/10.1007/s10787-014-0213-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-014-0213-0